Bristi Basu

11PUBLICATIONS
122CO-AUTHORS
Cancer geneticsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 24, 2025
Barriers to publishing early phase clinical trials: the oncologists' perspective.

Merel J J Lucassen, Pedro Bergmann, Olga Husson

|Sep 04, 2024
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors.

Babar Bashir, Judy S Wang, Gerald Falchook

|Oct 27, 2022
Radiomic and Volumetric Measurements as Clinical Trial Endpoints-A Comprehensive Review.

Ionut-Gabriel Funingana, Pubudu Piyatissa, Marika Reinius

|Oct 26, 2022
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer.

Filipe Correia Martins, Dominique-Laurent Couturier, Ines de Santiago

|Aug 19, 2022
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer.

Susana Banerjee, Vasiliki Michalarea, Joo Ern Ang

Pageof 2